Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Global Regulatory Systems01:28

Global Regulatory Systems

959
Global regulatory systems in bacteria enable rapid and coordinated responses to environmental changes by integrating sensory inputs with gene expression, ensuring efficient adaptation to fluctuating conditions. Key global regulatory mechanisms include regulons, two-component systems, sigma factors, and secondary messengers.Regulons and Global RegulatorsA regulon is a collection of genes and operons controlled by a common global regulator. These regulators enable bacteria to prioritize resource...
959
Microbial Interactions: Parasitism01:22

Microbial Interactions: Parasitism

108
Parasitism is a form of microbial interaction in which parasitic microbes exploit a host organism for nutrients and shelter, often at the host's expense. Unlike mutualistic relationships, where both organisms benefit, parasitism benefits only the parasite and harms the host.Classification of ParasitesMicrobial parasites are broadly classified based on their location relative to the host.Ectoparasites remain on the host’s surface, such as the skin or outer tissues, drawing nutrients...
108
Drug Control Governance: Regulatory Bodies and Their Impact01:03

Drug Control Governance: Regulatory Bodies and Their Impact

706
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
706
Microbial Interactions: Cooperation01:26

Microbial Interactions: Cooperation

59
Microbial cooperation involves beneficial interactions in which different species work together for individual or mutual advantage. These interactions can profoundly influence ecological dynamics and evolutionary processes, and they are essential to many pathogenic and symbiotic relationships.Nematode–Bacteria CooperationA striking example is the relationship between the Gram-negative bacterium Xenorhabdus nematophila and the parasitic nematode Steinernema carpocapsae. Juvenile nematodes...
59
Symbiosis00:58

Symbiosis

27.8K
Symbiotic relationships are long-term, close interactions between individuals of different species that affect the distribution and abundance of those species. When a relationship is beneficial to both species, this is called mutualism. When the relationship is beneficial to one species but neither beneficial nor harmful to the other species, this is called commensalism. When one organism is harmed to benefit another, the relationship is known as parasitism. These types of relationships often...
27.8K
Diversity of Protists II01:27

Diversity of Protists II

2.3K
Alveolates are a group of organisms recognized by the presence of alveoli, which are cytoplasmic sacs located beneath the cell membrane. While their function remains uncertain, alveoli may help regulate water balance by controlling how much water enters and leaves the cell. In dinoflagellates, these structures may serve as armor plates. There are three major types of alveolates: ciliates, which move using cilia; dinoflagellates, which use flagella for movement; and apicomplexans, which are...
2.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spatial atlas of diabetic kidney disease reveals a B cell-rich subgroup.

Nature·2026
Same author

The role of integrins in T cell-mediated resistance to <i>Cryptosporidium parvum</i>.

bioRxiv : the preprint server for biology·2026
Same author

Pharmacological reduction of neutrophil infiltration reduces <i>Clostridioides difficile</i> infection severity.

mBio·2026
Same author

Interleukin-27 is antiviral against Zika virus at the maternal-fetal interface.

Nature communications·2025
Same author

IL-27 limits HSPC differentiation during infection and protects from stem cell exhaustion.

eLife·2025
Same author

Cell-Specific Inducible Human <i>APOL1</i> Risk Variant Expression in Mice Causes Hypertension and Renal Damage.

Circulation·2025

Related Experiment Video

Updated: May 3, 2026

A Parasite Rescue and Transformation Assay for Antileishmanial Screening Against Intracellular Leishmania donovani Amastigotes in THP1 Human Acute Monocytic Leukemia Cell Line
12:22

A Parasite Rescue and Transformation Assay for Antileishmanial Screening Against Intracellular Leishmania donovani Amastigotes in THP1 Human Acute Monocytic Leukemia Cell Line

Published on: December 30, 2012

24.5K

A parasite partner for regulatory affairs.

Isabella O Conway1, Christopher A Hunter1

  • 1Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Science Immunology
|May 1, 2026
PubMed
Summary

A novel parasite-derived cytokine shows promise for engineering regulatory T cell (Treg) therapies to combat inflammation. This discovery offers a new strategy for Treg cell therapy development.

Area of Science:

  • Immunology
  • Parasitology
  • Cell Therapy

Background:

  • Regulatory T cells (Treg) are crucial for immune homeostasis and preventing autoimmunity.
  • Current Treg cell-based therapies face challenges in effectively modulating immune responses.
  • Inflammation underlies many chronic diseases, necessitating novel therapeutic approaches.

Purpose of the Study:

  • To investigate the potential of a parasite-derived cytokine in enhancing Treg cell function.
  • To explore the feasibility of using this cytokine for Treg cell therapy development.
  • To identify new strategies for mitigating inflammation through Treg cell modulation.

Main Methods:

  • Identification and characterization of a specific cytokine from a parasitic organism.
  • In vitro assays to assess the cytokine's effect on Treg cell proliferation, stability, and suppressive function.

More Related Videos

Methods to Investigate the Regulatory Role of Small RNAs and Ribosomal Occupancy of Plasmodium falciparum
10:22

Methods to Investigate the Regulatory Role of Small RNAs and Ribosomal Occupancy of Plasmodium falciparum

Published on: December 4, 2015

8.2K
Preventing the Spread of Malaria and Dengue Fever Using Genetically Modified Mosquitoes
17:50

Preventing the Spread of Malaria and Dengue Fever Using Genetically Modified Mosquitoes

Published on: July 4, 2007

11.9K

Related Experiment Videos

Last Updated: May 3, 2026

A Parasite Rescue and Transformation Assay for Antileishmanial Screening Against Intracellular Leishmania donovani Amastigotes in THP1 Human Acute Monocytic Leukemia Cell Line
12:22

A Parasite Rescue and Transformation Assay for Antileishmanial Screening Against Intracellular Leishmania donovani Amastigotes in THP1 Human Acute Monocytic Leukemia Cell Line

Published on: December 30, 2012

24.5K
Methods to Investigate the Regulatory Role of Small RNAs and Ribosomal Occupancy of Plasmodium falciparum
10:22

Methods to Investigate the Regulatory Role of Small RNAs and Ribosomal Occupancy of Plasmodium falciparum

Published on: December 4, 2015

8.2K
Preventing the Spread of Malaria and Dengue Fever Using Genetically Modified Mosquitoes
17:50

Preventing the Spread of Malaria and Dengue Fever Using Genetically Modified Mosquitoes

Published on: July 4, 2007

11.9K
  • Pre-clinical models to evaluate the therapeutic efficacy of cytokine-engineered Treg cells in inflammatory conditions.

    • Main Results:

    • The parasite-derived cytokine significantly enhanced Treg cell suppressive capacity and stability.
    • Engineered Treg cells demonstrated potent anti-inflammatory effects in pre-clinical models.
    • The cytokine treatment promoted Treg cell expansion without compromising their essential functions.

    Conclusions:

    • Parasite-derived cytokines represent a promising avenue for developing advanced Treg cell therapies.
    • This approach offers a potential breakthrough for treating inflammatory and autoimmune diseases.
    • Further research is warranted to translate these findings into clinical applications for Treg cell therapy.